A comparative in vivo study of hyperthermic intraperitoneal chemotherapy with cisplatin versus doxorubicin versus cisplatin plus doxorubicin for the treatment of intra‐abdominally disseminated alveolar rhabdomyosarcoma in mice DOI Open Access
Illya Martynov, Jens Gesche,

Lajwanti Dhaka

et al.

Pediatric Blood & Cancer, Journal Year: 2024, Volume and Issue: 71(12)

Published: Oct. 7, 2024

Treatment options for advanced intra-abdominal pediatric rhabdomyosarcoma (RMS) with peritoneal sarcomatosis (PS) include cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). However, optimal dosages combination regimens of drugs used HIPEC are underexplored. We aimed to evaluate the efficacy cisplatin, doxorubicin, their in vivo.

Language: Английский

A comparative in vivo study of hyperthermic intraperitoneal chemotherapy with cisplatin versus doxorubicin versus cisplatin plus doxorubicin for the treatment of intra‐abdominally disseminated alveolar rhabdomyosarcoma in mice DOI Open Access
Illya Martynov, Jens Gesche,

Lajwanti Dhaka

et al.

Pediatric Blood & Cancer, Journal Year: 2024, Volume and Issue: 71(12)

Published: Oct. 7, 2024

Treatment options for advanced intra-abdominal pediatric rhabdomyosarcoma (RMS) with peritoneal sarcomatosis (PS) include cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). However, optimal dosages combination regimens of drugs used HIPEC are underexplored. We aimed to evaluate the efficacy cisplatin, doxorubicin, their in vivo.

Language: Английский

Citations

0